News 
Xgene Corporation Lands National Institutes of Health Grant 




 

June 5, 2004 - Xgene Corporation has successfully competed for a SBIR (Small Business Innovative Research) grant from the National Institutes of Health. The grant is for characterizing Xgene's promising AccuskinTM product. "The grant from the NIH illustrates a positive momentum for AccuskinTM, and further validates our unique technology," says Dr. Warren Hoeffler our CEO.